Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer: Randomised Trial Comparing Toxicity Between 2 Different Hypofractionated Schedules

NCT01921803 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT01921803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01921803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer: Randomised Trial Comparing Toxicity Between 2 Different Hypofractionated Schedules
Lead sponsor
University Hospital, Ghent
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2013
Completion date
July 14, 2020
Enrollment
346 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer